MDR class IIa approved
Certified for Europe
TGA approved
ISO 13485 certified
MDR class IIa approved
CE (0344) certified
ISO 13485 certified
Business & integration partners
Research & innovation partners
RetCAD allows for accurate diagnosis and efficient screening for eye diseases. Thirona’s expertise in artificial intelligence and clinical knowledge make them a valuable partner for bringing AI tools to the clinical routine.
Dr. Toam Katz
Ophthalmologist and senior physician
University Medical Center Hamburg-Eppendorf (UKE)
What I really like about RetCAD is the accuracy of the software in combination with the simplicity of use. Moreover, I greatly appreciate the level of service support from Thirona.
Dr. Dave Block
Ophthalmologist and owner
Eye Care
Next level eye care diagnostics
With global costs of vision loss estimated to be nearly $3 trillion and up to 80% cases of retinal diseases causing visual impairment or blindness that can often be prevented if detected timely, artificial intelligence opens up a whole new possibilities in eye care. Imaging is non-invasive and reliable screening method but requires expertise to analyse/read the acquired images. Using artificial intelligence, this can be done quickly, yet accurately.
RetCAD™ uses state-of-the-art deep learning and computer vision technology utilizing a large amount of retinal images in order to provide precisely quantified clinical evidence. The software assists eye care specialists in early diagnosis and grading of vision threatening diseases, such as Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). Simplified visualization of the scan analysis with heat maps help improve patient engagement and prevent severe eyesight problems and blindness.